Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Liver    symbols : Asmb    save search

Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
Published: 2023-11-10 (Crawled : 13:00) - globenewswire.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 4.47% H: 1.21% C: -4.32%

meeting hepatitis liver
Assembly Biosciences to Present New Data at AASLD The Liver Meeting®
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: -4.16% H: 11.6% C: 5.71%

meeting liver
Assembly Biosciences Presents New Data Highlighting Entry Inhibitor and Core Inhibitor Programs at EASL’s International Liver Congress™ 2023
Published: 2023-06-21 (Crawled : 12:00) - globenewswire.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 1.87% H: 6.42% C: 2.75%

liver international
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL International Liver Congress™ 2023
Published: 2023-06-07 (Crawled : 12:00) - globenewswire.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: -0.91% H: 2.75% C: 1.83%

liver international
Assembly Biosciences Presents New Data at AASLD The Liver Meeting® Highlighting Breadth of Virology Portfolio and Potential of Next-Generation Core Inhibitors in HBV
Published: 2022-11-04 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 1.87% H: 0.0% C: -6.75%

meeting liver potential
Arbutus Presents AB-729 Clinical Data and AB-101 Preclinical Data at AASLD - The Liver Meeting®
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 2.44% H: 1.19% C: -1.79%
ABUS | $2.725 -0.18% -0.18% 930K twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 4.24% C: 2.54%

ab-729 meeting liver preclinical ab-101
Assembly Biosciences to Present Data in Four Poster Presentations at Upcoming AASLD The Liver Meeting®
Published: 2022-10-24 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 5.81% C: 3.23%

meeting liver
Assembly Biosciences Presents New Data Highlighting Clinical Progress of Core Inhibitor Programs at EASL’s International Liver Congress™ 2022
Published: 2022-06-22 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.98% H: 4.83% C: 4.35%

liver international
Assembly Biosciences to Highlight Data from HBV Core Inhibitor Programs at EASL’s International Liver Congress™ 2022
Published: 2022-06-08 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 1.96% H: 4.81% C: 2.4%

liver international
Assembly Biosciences Presents New Data at AASLD The Liver Meeting™ Highlighting the Progress of its HBV Core Inhibitor Portfolio
Published: 2021-11-12 (Crawled : 17:00) - biospace.com/
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 1.73% H: 0.0% C: 0.0%

liver
Assembly Biosciences Abstracts Selected for Presentation at the Upcoming AASLD The Liver Meeting®
Published: 2021-11-01 (Crawled : 15:00) - globenewswire.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: -0.63% H: 2.56% C: 1.6%

presentation liver bioscience
Assembly Biosciences Presents Data from HBV Core Inhibitor Programs at the International Liver Congress™ EASL 2021
Published: 2021-06-23 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 2.27% H: 0.74% C: -1.97%

liver bioscience
Assembly Biosciences to Present Data from HBV Core Inhibitor Programs at The International Liver Congress™ EASL 2021
Published: 2021-06-09 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 5.83% C: 5.34%

liver
Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™
Published: 2020-11-13 (Crawled : 13:54) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.9% H: 2.68% C: 0.54%

liver
Gainers vs Losers
67% 33%

Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K twitter stocktwits trandingview |
Energy Minerals

KUKE | $2.88 2.49% 7.64% 360K twitter stocktwits trandingview |

CXM 4 | $11.34 -0.44% 4.27% 1.7M twitter stocktwits trandingview |
Information

PVL 4 | $1.47 -0.68% 4.08% 77K twitter stocktwits trandingview |
Energy Minerals

RNR 4 | $224.74 0.85% 3.52% 310K twitter stocktwits trandingview |
Finance

PZG | $0.4431 0.48% 2.91% 150K twitter stocktwits trandingview |
Non-Energy Minerals

SIX | $23.45 -0.55% 0.68% 650K twitter stocktwits trandingview |
Consumer Services

NEWP | $1.97 0.61% 310K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...

KNSL 4 | $451.81 -0.02% 0.49% 140K twitter stocktwits trandingview |
Finance

SENS | $0.3992 -4.04% 0.45% 2M twitter stocktwits trandingview |
Electronic Technology


Your saved searches
Save your searches and get alerts when important news are released.